WELL Health Technologies (WELL) Stock Price, News & Analysis

Company Overview

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services - Primary includes clinical operations and allied health. Omni-channel Patient Services - Specialized comprises CRH and MyHealth under two segments. Virtual Services include EMR, billing and revenue cycle management solutions, digital apps, and cybersecurity.

Key Stats

• Today's Range: C$4.12 to C$4.27
• 50-Day Range: C$3.64 to C$4.37
• 52-Week Range: C$3.58 to C$6.08
• Volume: 1.36 million shs
• Average Volume: 1.48 million shs
• Market Capitalization: C$1.07 billion
• P/E Ratio: 37.91
• Dividend Yield: N/A
• Price Target: C$6.25
• Consensus Rating: Buy

WELL Health Technologies Stock Analysis - MarketRank™

WELL Health Technologies scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

WELL Health Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

WELL Health Technologies has a consensus price target of C$6.25, representing about 49.9% upside from its current price of C$4.17.

Amount of Analyst Coverage

WELL Health Technologies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of WELL Health Technologies is 37.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.94.

Price to Earnings Ratio vs. Sector

The P/E ratio of WELL Health Technologies is 37.91, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.99.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for WELL Health Technologies, their PEG ratio cannot be calculated.

Price to Book Value per Share Ratio

WELL Health Technologies has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for WELL.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

WELL Health Technologies does not currently pay a dividend.

Dividend Growth

WELL Health Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

26 people have searched for WELL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

2 people have added WELL Health Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, WELL Health Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.80% of the stock of WELL Health Technologies is held by insiders.

Percentage Held by Institutions

5.28% of the stock of WELL Health Technologies is held by institutions.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 5/23/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Trading
• Current Symbol: TSE:WELL
• CIK: N/A
• Web: www.well.company
• Phone: 604 628 7266
• Fax: N/A
• Employees: 510
• Year Founded: N/A

Price Target and Rating

• Average Price Target for WELL Health Technologies: C$6.25
• High Price Target: C$6.50
• Low Price Target: C$6.00
• Potential Upside/Downside: +49.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.11
• Trailing P/E Ratio: 37.91
• Forward P/E Ratio: 13.90
• P/E Growth: -1.93
• Net Income: C$73.76 million
• Net Margins: 1.82%
• Pretax Margin: N/A
• Return on Equity: 3.15%
• Return on Assets: 2.07%

Debt

• Debt-to-Equity Ratio: 91.15
• Current Ratio: 0.83
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: C$1.47 billion
• Price / Sales: 0.72
• Cash Flow: C$0.34 per share
• Price / Cash Flow: 12.27
• Book Value: C$4.11 per share
• Price / Book: 1.01

Miscellaneous

• Outstanding Shares: 255,409,000
• Free Float: N/A
• Market Cap: C$1.07 billion
• Optionable: Not Optionable
• Beta: 0.93